How individuals, and health care professionals, deal with infection from SARS-CoV-2, the virus that causes COVID-19, varies depending on the severity of the infection.
COVID-19 patients experience a wide range of disease severity. Why do some people get severe and life-threatening illness, while others suffer no symptoms or just mild ones?
Researchers show that the wallflower is an excellent model plant for discovering new cardenolides that could be used to treat heart disease and cancer.
The Partners of Citadel and Citadel Securities have made a $2 million gift to Weill Cornell Medicine to develop new approaches to protect people from COVID-19 and identify new cases of it.
To ease the transition to remote learning, Cornell University Library in early April began loaning out laptops to students who need them; the loans are for the spring semester, with the possibility of renewal.
Rural counties in upstate New York are likely to be the state’s most vulnerable to a COVID-19 outbreak that could strain local health care infrastructure, according to an analysis by Cornell demographers.
Mathematical modeling by Weill Cornell Medicine is helping to guide New York state and New York City leaders as they make decisions that could affect the trajectory of the COVID-19 pandemic.
With lives and livelihoods on pause due to COVID-19, Cornell’s Institute of Politics and Global Affairs hosted a TeleTown Hall April 8 to explore a potential timeline for treatment.
